| Cardiovascular actions and therapeutic potential of tanshinone IIA S Gao, Z Liu, H Li, PJ Little, P Liu, S Xu Atherosclerosis 220 (1), 3-10, 2012 | 348 | 2012 |
| Flavonoid biosynthetic pathways in plants: Versatile targets for metabolic engineering SM Nabavi, D Šamec, M Tomczyk, L Milella, D Russo, S Habtemariam, ... Biotechnology advances 38, 107316, 2020 | 300 | 2020 |
| Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation D Kamato, ML Burch, TJ Piva, HB Rezaei, MA Rostam, S Xu, W Zheng, ... Cellular signalling 25 (10), 2017-2024, 2013 | 296 | 2013 |
| LOX-1 in atherosclerosis: biological functions and pharmacological modifiers S Xu, S Ogura, J Chen, PJ Little, J Moss, P Liu Cellular and Molecular Life Sciences 70, 2859-2872, 2013 | 282 | 2013 |
| Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies S Xu, I Ilyas, PJ Little, H Li, D Kamato, X Zheng, S Luo, Z Li, P Liu, J Han, ... Pharmacological Reviews 73 (3), 924-967, 2021 | 252 | 2021 |
| Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics Z Li, S Xu, P Liu Acta Pharmacologica Sinica 39 (5), 802-824, 2018 | 248 | 2018 |
| Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics X Feng, A Sureda, S Jafari, Z Memariani, D Tewari, G Annunziata, ... Theranostics 9 (7), 1923, 2019 | 234 | 2019 |
| Curcumin, the golden spice in treating cardiovascular diseases H Li, A Sureda, HP Devkota, V Pittalà, D Barreca, AS Silva, D Tewari, ... Biotechnology advances 38, 107343, 2020 | 208 | 2020 |
| Antioxidants in cardiovascular therapy: panacea or false hope? K Goszcz, SJ Deakin, GG Duthie, D Stewart, SJ Leslie, IL Megson Frontiers in cardiovascular medicine 2, 29, 2015 | 192 | 2015 |
| Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-κB signaling pathway Q Jiang, P Liu, X Wu, W Liu, X Shen, T Lan, S Xu, J Peng, X Xie, H Huang Molecular and cellular endocrinology 331 (1), 34-40, 2011 | 163 | 2011 |
| Evaluation of foam cell formation in cultured macrophages: an improved method with Oil Red O staining and DiI-oxLDL uptake S Xu, Y Huang, Y Xie, T Lan, K Le, J Chen, S Chen, S Gao, X Xu, X Shen, ... Cytotechnology 62, 473-481, 2010 | 158 | 2010 |
| Tanshinone II-A: new perspectives for old remedies S Xu, P Liu Expert opinion on therapeutic patents 23 (2), 149-153, 2013 | 144 | 2013 |
| Cryptotanshinone suppressed inflammatory cytokines secretion in RAW264. 7 macrophages through inhibition of the NF-κB and MAPK signaling pathways S Tang, XY Shen, HQ Huang, SW Xu, Y Yu, CH Zhou, SR Chen, K Le, ... Inflammation 34, 111-118, 2011 | 131 | 2011 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 114 | 2022 |
| Atherosclerosis is an epigenetic disease S Xu, J Pelisek, ZG Jin Trends in Endocrinology & Metabolism 29 (11), 739-742, 2018 | 113 | 2018 |
| Targeting mechanosensitive transcription factors in atherosclerosis N Niu, S Xu, Y Xu, PJ Little, ZG Jin Trends in pharmacological sciences 40 (4), 253-266, 2019 | 111 | 2019 |
| COVID-19 and Kawasaki disease in children S Xu, M Chen, J Weng Pharmacological research 159, 104951, 2020 | 105 | 2020 |
| ATP-citrate lyase (ACLY) in lipid metabolism and atherosclerosis: An updated review X Feng, L Zhang, S Xu, A Shen Progress in lipid research 77, 101006, 2020 | 104 | 2020 |
| Loss of LMOD1 impairs smooth muscle cytocontractility and causes megacystis microcolon intestinal hypoperistalsis syndrome in humans and mice D Halim, MP Wilson, D Oliver, E Brosens, JBGM Verheij, Y Han, V Nanda, ... Proceedings of the National Academy of Sciences 114 (13), E2739-E2747, 2017 | 104 | 2017 |
| Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics S Xu, D Kamato, PJ Little, S Nakagawa, J Pelisek, ZG Jin Pharmacology & therapeutics 196, 15-43, 2019 | 99 | 2019 |
